Pandemic Fallout to Delay US Drug Price Reform, Biosimilars Uptake
1:15
Legislation to lower prescription drug prices will take a backseat to containing the coronavirus pandemic and economic stimulus in the near term, delaying a potential uptick in biosimilars.